Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Nustay enters its first agreement regarding a Business-to-Business API and delivers 2020 goal

Today, Nustay A/S (“Nustay”) announces that the company has entered into an agreement regarding a B2B API (application program interface), which allows the counterpart in the agreement to tap into Nustay’s competitive hotel inventory. The counterpart is a hotel booking site with a unique business model specialized in hotel deals for businesses. Within the co-operation, Nustay will act as a B2B hotel supplier and the counterpart will be able to submit hotel reservations through Nustay on behalf of its end-users. The agreement is valid from the signing and remains in full force and effect until

NextCell and Cellaviva are highlighted by KI Innovations

The stem cell company NextCell Pharma (“NXTCL”) announces that the company and its stem cell bank Cellaviva are highlighted by Karolinska Institutet Innovations as a positive example in its Jubilee book “20 year of innovation @ Karolinska Institutet”. Of nearly 400 innovations, NextCell and a further 19 examples have been selected to represent the social benefits that research of KI has contributed during the past 20 years.Cellaviva was founded by researchers at Karolinska Institutet with help from Karolinska Institutet Innovations AB. The company became the first private stem cell bank in

Bravida’s Annual Report 2018 is published

Bravida Holding AB’s Annual Report 2018 has been published in Swedish and is available at the corporate website: http://www.bravida.se/finansiella-rapporter/– 2018 was another record year for Bravida, with great earnings and plenty of good acquisitions. We are pleased with the results, but view this more as confirmation that our business model is working. The next step is to take profitability to the next level while continuing to grow. Shareholders and other interested parties who wish to receive a printed copy of the Annual Report 2018 may order it through e-mail or telephone. E-

Aaro Cantell Nominated Interim CEO of Normet

Normet’s board of directors has nominated Aaro Cantell as the interim CEO starting April 1st, 2019.The intention is that Aaro will hold the position until permanent CEO is chosen and joins Normet. Robin Lindahl, current President and CEO will step down at the same date and support the handover as needed during April.  “I am confident we can find the right candidate to take us to the next level with our growth story and to drive future success of Normet. We have a strong management team in place, which will continue to drive the business forward”, says Aaro Cantell. More Information

Change in number of shares and votes in Arise AB (publ)

During March, the number of shares and votes in Arise AB (publ) has increased due to the exercise of warrants issued under an incentive program. As of 29 March 2019, the number of shares and votes in Arise AB (publ) amounts to 33,545,570. Halmstad, 29 March 2019 ARISE AB (publ)                                         For further information, please contact:Linus Hägg, CFO Arise AB, +46 702 448 916 The information in the press release is such that Arise AB (publ) is required to disclose pursuant to the Swedish Financial Instruments Trading Act. The information was submitted for

Orkla seeks to purchase leading supplier of confectionery, bakery and ice cream ingredients

Through its wholly-owned subsidiary Orkla Food Ingredients AS, Orkla has entered into an agreement to purchase the majority of the shares in the Greek company Stelios Kanakis Industrial and Commercial S.A. ("Kanakis"). Kanakis is market leader in the sale and distribution of confectionery, bakery and ice cream ingredients in Greece. Kanakis is listed on the Athens stock exchange, and the founder and his family own approximately 86% of the shares. Orkla has entered into an agreement to acquire approx. 65.8% from Stelios and Maria Kanakis at a purchase price per share of EUR 4.35. In

Change in number of shares andvotes in Beijer Electronics Group

The total number of shares in Beijer Electronics Group AB (publ) as per 29 March 2019 amounts to 28,786,102, divided into 28,601,379 ordinary shares and 184,723 class C shares, corresponding to a total of 28,619,851.3 votes.The increased number of shares and votes is due to a new share issue of 150,066 class C shares within the company’s incentive program LTI 2018/2021. The company holds all class C shares. The shares are intended to be used for hedging of obligations under the incentive program.

Clas Ohlson opens a new store in Kungälv, Sweden

At 5 pm CET yesterday, Clas Ohlson opened a new store in Kungälv in conjunction with the grand opening of the new Kongahälla Shopping Centre.As well as a broad product range and first class customer service, the store offers customers Click and Collect – a service that is a mix of digital and physical shopping, where a customer orders a product online and collects it in the store within four hours. In addition, products that are not in the normal assortment can be ordered by a customer to the store and will be ready for pick up a few days later. “With our new store in Kongahälla Shopping

NOTE’s Annual Report 2018

As of today, the Swedish version of NOTE’s Annual Report 2018 is available at the website, www.note.eu. Financial Calendar 2019Interim Report January–March                     25 AprilInterim Report January–June                       15 JulyInterim Report January–September              22 October For more information, please contact:Johannes Lind-Widestam, CEO and President, tel. +46 (0)70 541 7222  Henrik Nygren, CFO, tel. +46 (0)70 977 0686 About NOTENOTE is one of northern Europe’s leading EMS partners, producing PCBAs, subassemblies and box build products. NOTE’s

PSV contracts awarded

Solstad Offshore has signed a contract with Shell Brasil Petroleo Ltda (Shell) for the PSV Normand Starling (2013, STX PSV 08 CD, 4000 DWT). The contract will commence in 2Q 2019 and have a firm duration of 2 years. Normand Starling will support Shell’s activities in Brazilian waters. In addition, Solstad has been awarded contracts with an undisclosed client for two of the company’s PSVs with commencement early 2Q 2019. The contract duration for each vessel is 185 days firm plus options. Skudeneshavn March 29th, 2019 ContactsLars Peder Solstad CEO, at +47 91 31 85 85Anders

Talkpool Year-end report January-December 2018

OCT 1st – DEC 31st 2018 · Net sales amounted to EUR 6 908 thousand (6 123), a 12.8 percent increase · EBITDA of EUR 329 thousand (333) and EBITDA margin of 4.8 percent (5.4) · EBIT of EUR 230 thousand (220) and EBIT margin 3.3 percent (3.6) · Loss after tax of negative EUR 687 thousand (-175) JAN 1st – DEC 31st 2018 · Net sales amounted to EUR 24 363 thousand (16 379), a 48.7 percent increase · EBITDA of EUR 1 068 thousand (359) and EBITDA margin of 4.4 percent (2.2) · EBIT of EUR 733 thousand (193) and EBIT margin · 3.0 percent (1.2) · Loss after tax of

Notice to Annual General Meeting in Probi AB (publ)

The shareholders of Probi AB (publ), reg. no. 556417-7540, are hereby officially convened to the Annual General Meeting (AGM) which will be held on Tuesday 7 May 2019 at 3:00 p.m. at Elite Hotel, Ideon Gateway, Scheelevägen 27, Lund, Sweden. Right to participate To be entitled to participate in the AGM shareholders must be registered in the shareholders’ register maintained by Euroclear Sweden AB as of Tuesday 30 April 2019 and have notified the company of their intention to participate no later than Tuesday 30 April 2019, preferably before 4:00 p.m. Shareholders whose shares are

Danish cannabis production due to start shortly

In its September 2018 IPO Memorandum, STENOCARE provided guidance that cultivation of cannabis plants in its Danish production facility was expected during Q1. This milestone is yet to be fulfilled due to a delay in receipt of the plant seedling export certificate from the Canadian authorities. The timing of when the export certificate will be obtained is outside the company’s control. All other preparations and approvals required are in place and as soon as the export certificate is received, 1st stage local production will commence in STENOCARE’s own facility in Denmark. With this,

Induct - First ad-based revenue generated on the extended platform

Induct has started to use Google’s Ad Manager platform to manage the ad-based business model for the next generation Induct platform. “We are just in time to reach our milestone of generating our first ad-based revenues in Q1” says CEO Alf Martin Johansen in Induct. Induct opened its new extended platform for external users February 1st earlier this year. Until now, selected users have been on the platform and provided insight and improvements for further development. “We have achieved a milestone we have been looking forward to for a long time, started to generate ad revenues”

AYIMA GROUP AB (publ) CONDUCTS A RIGHTS ISSUE OF 13.6 MSEK, GUARANTEED BY 85%

The Board of Directors of Ayima Group AB (publ) ("Ayima" or "the Company") has decided to carry out a rights issue of approximately 13.6 MSEK. 2018 was Ayima's first full year as a listed company, a year during which the organization has taken big steps forward. The growth is strong, with sales for 2018 increasing by 28%. For 2019, Ayima continues to show good momentum with several new client wins. Even though growth is strong, the result is in the negative territory. Ayima has therefore made a decision, which has previously been communicated to the market, that during the first quarter

AYIMA GROUP AB (publ) GENOMFÖR FÖRETRÄDESEMISSION OM 13,6 MSEK, GARANTERAD TILL 85 %

Styrelsen för Ayima Group AB (publ) (”Ayima” eller ”Bolaget”) har beslutat om att genomföra en företrädesemission om cirka 13,6 MSEK. 2018 var Ayimas första hela år som ett börsnoterat företag, ett år under vilket organisationen har tagit stora steg framåt. Tillväxten är stark där omsättningen för 2018 ökade med 28 %. Under 2019 visar Ayima fortsatt bra momentum med flera vunna kundavtal. Även om tillväxten är stark är dock resultatet negativt. Ayima har därför tagit ett beslut, vilket tidigare redan har kommunicerats till marknaden, att Bolaget under första kvartalet 2019 genomför

KALLELSE TILL EXTRA BOLAGSSTÄMMA I AYIMA GROUP AB (publ)

Aktieägarna i Ayima Group AB (publ), org. nr. 559095-9291, (“Bolaget”) kallas härmed till extra bolagsstämma tisdag den 16 april 2019 kl. 11.00 i Bolagets lokaler på Birger Jarlsgatan 18A, 5 trappor, Stockholm. Aktieägare som önskar delta vid den extra bolagsstämman ska vara införd i den av Euroclear Sweden AB förda aktieboken onsdag den 10 april 2019. Vidare ska aktieägare som önskar delta på stämman anmäla detta till Bolaget senast onsdag den 10 april 2019. Anmälan om deltagande sker: · per post: Ayima Group AB (publ), Birger Jarlsgatan 18A, 114 34 Stockholm,  · per telefon:

Karnov Group publishes prospectus for Initial Public Offering on Nasdaq Stockholm

Karnov Group AB (publ) (“Karnov” or the “Company”), a leading provider of information services and products in the areas of legal, tax and accounting and environmental, health and safety in Denmark and Sweden, announced on 20 March 2019 its intention to launch an initial public offering of its shares (the “Offering”) and to list its shares on Nasdaq Stockholm. The prospectus for the Offering will be published today and the first day of trading is expected to be 11 April 2019.NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA,

NOTICE OF EXTRA GENERAL MEETING IN AYIMA GROUP AB (publ)

The shareholders of Ayima Group AB (publ), corporate identity number 559095-9291, (“Ayima” or “the Company”) are hereby invited to the Extra General Meeting (“EGM”) on Tuesday April 16th2019 at 11.00 a.m. at the Company’s premises at Birger Jarlsgatan 18A, 5 tr, Stockholm. Shareholders that wish to attend the Extra General Meeting are to be entered in the register kept by Euroclear Sweden AB by the 10thof April 2019. In addition, shareholders wishing to attend the EGM must notify the Company by 10thof April 2019. Participation notice: · by post: Ayima Group AB (publ), Birger

Investor AB’s 2018 Annual Report now available online

Today, Investor announced that its complete Annual Report 2018 including the Sustainability Report is available at www.investorab.com. Printed copies will soon be available for distribution. In 2018, Investor’s total shareholder return was 4 percent, outperforming the Swedish stock market by 8 percentage points. More importantly, many of our companies and Investor itself took significant steps that we believe will create long-term value. Within Listed Core Investments, Epiroc became our 12th listed core investment following its spin-off from Atlas Copco. We invested SEK 3.4 bn. in

DDM exits Russia and realises a significant gain

DDM Debt AB (Nasdaq Stockholm: DDM2) announces that the group has sold its legacy portfolios in Russia. The transaction results in a realised gain of approximately EUR 2 million. Henrik Wennerholm, CEO of DDM, comments: “This transaction demonstrates the underlying value of our portfolios and ERC, and will enable us to focus further on our key markets.” This is information which DDM Debt AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 08:30 CET on 29 March

Amended number of shares and votes in NeuroVive Pharmaceutical AB (publ)

Lund, Sweden, 29 March 2019 - NeuroVive Pharmaceutical AB(Nasdaq Stockholm: NVP, OTCQX: NEVPF), today announced an increase of the number of shares and votes in NeuroVive of 22,594,467 as a result of a fully performed preferential rights issue, resolved by the Board of Directors on 10 December 2018 and approved at the Extraordinary General Meeting on 17 January 2019, and a conducted directed new issue of shares on 7 March 2019.Today, the last trading day of the month, there are in total 185,952,591 shares and votes in NeuroVive Pharmaceutical AB.  This information is information that

Change in the number of shares and votes in Q-linea AB

Q-linea AB (publ) (”Q-linea” or ”the Company”), today announced that the number of shares and votes in Q-linea has increased during the month of March due to the new share issue carried out to ensure delivery of performance shares within the framework of the long-term incentive programme that was resolved by the extraordinary general meeting on 12 November 2018. A total of 211,048 shares and votes have been added. At 29 March 2019, which is the last trading day in March, the number of shares and votes in the Company amounts to 23,117,963. All shares are ordinary shares. For further

Catena’s Annual Report for 2018 has been published

29 March 2019, 8:30 a.m. Catena’s Annual Report for 2018 has now been published on the company´s website, www.catenafastigheter.com. The Annual General Meeting will be held in Stockholm on 25 April 2019. Printed copies of the Annual Report will be available on order in April. Both the Swedish original and an English translation of the Annual Report are available from today on Catena’s website. For further information, please contact Benny Thögersen, CEO                                           Tel. +46 706-60 83 50                                              benny.

There are no items matching the current filter
There are no more items matching the current filter
Back to top